Insights

Learn More

Recent work

Learn More

Careers

Learn more

Qualified professionals

Learn more

Trainee & intern programmes

Learn more

Offices

New York

Learn more

San Francisco

Learn more
A&L Goodbody logo
Irish merger control developments for life sciences clients Q1 2026

EU, Competition & Procurement

Irish merger control developments for life sciences clients Q1 2026

Wed 03 Jun 2026

2 min read

Irish merger control is entering a new phase, with significant implications for businesses, particularly in the life sciences sector. In this podcast, Dervla Broderick and Peter Murphy examine developments and what they mean in practice:

The mandatory notification thresholds are no longer the boundary of CCPC oversight. For deal teams, this puts a premium on early identification of competition risks and, where a sub-threshold transaction has a credible Irish competition dimension, considered engagement with the CCPC before or shortly after signing.

View transcript

For further information in relation to this topic, please contact Dervla Broderick, Partner, or any member of ALG's EU, Competition & Procurement group.

Date published: 3 June 2026

Key Contacts